We are live on ! Find out more
COGT icon

Cogent Biosciences

47 hedge funds and large institutions have $62.8M invested in Cogent Biosciences in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 9 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 9

0.91% less ownership

Funds ownership: 12.82%11.9% (-0.91%)

9% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 11

2% less funds holding

Funds holding: 4847 (-1)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

60% less capital invested

Capital invested by funds: $158M → $62.8M (-$94.9M)

Holders
47
Holders Change
-1
Holders Change %
-2.08%
% of All Funds
1.05%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
10
Increased
22
Reduced
9
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
26
Wells Fargo
California
$171K +$169K +5,701 +142%
Charles Schwab
27
Charles Schwab
California
$169K +$283K +9,548 New
JP Morgan Chase
28
JP Morgan Chase
New York
$168K +$130K +4,389 +85%
Marshall Wace
29
Marshall Wace
United Kingdom
$138K +$233K +7,869 New
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$131K +$180K +6,092 +449%
TA
31
Teachers Advisors
New York
$112K +$188K +6,370 New
TCIM
32
TIAA CREF Investment Management
New York
$105K +$176K +5,957 New
Goldman Sachs
33
Goldman Sachs
New York
$94K +$65.2K +2,205 +70%
AllianceBernstein
34
AllianceBernstein
Tennessee
$59K
QSS
35
Quantitative Systematic Strategies
Florida
$57K +$96K +3,244 New
AIG
36
American International Group
New York
$55K +$75.3K +2,545 +433%
ProShare Advisors
37
ProShare Advisors
Maryland
$53K +$89.9K +3,038 New
VOYA Investment Management
38
VOYA Investment Management
Georgia
$49K +$82.2K +2,778 New
Citigroup
39
Citigroup
New York
$19K +$25.3K +855 +350%
TRCT
40
Tower Research Capital (TRC)
New York
$18K +$27.3K +922 +831%
Legal & General Group
41
Legal & General Group
United Kingdom
$13K +$16.4K +554 +296%
SO
42
STRS Ohio
Ohio
$4K
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$2K
MAM
44
Meeder Asset Management
Ohio
$2K +$3.88K +131 +336%
AIP
45
Ameritas Investment Partners
Nebraska
$1K
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
$1K +$1.8K +61 +1,017%
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$277 -$385 -13 -45%
Jennison Associates
48
Jennison Associates
New York
-$9.17M -222,508 Closed
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
-$317K -7,699 Closed
Citadel Advisors
50
Citadel Advisors
Florida
-$235K -5,699 Closed

COGT Hedge Fund Activity: Q4 2018 in Review

47 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q4 2018, worth a combined $62.8M — down 60% from $158M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of COGT and 10 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 22 added.

The largest buyer was BlackRock, adding an estimated $8.35M. The largest seller was Fidelity Investments, cutting an estimated $10.8M.

  • 47 institutional investors held Cogent Biosciences (COGT) as of Q4 2018, down from 48 in Q3 2018.
  • Funds reported $62.8M of Cogent Biosciences stock for Q4 2018, down 60% quarter-over-quarter.
  • 10 funds opened new Cogent Biosciences positions in Q4 2018 and 11 closed out, a net change of -1 holder.
  • The largest Cogent Biosciences buyer in Q4 2018 was BlackRock, an estimated $8.35M added.
  • The largest Cogent Biosciences seller in Q4 2018 was Fidelity Investments, an estimated $10.8M sold.

Based on aggregated 13F filings for Q4 2018.